eMedicine Specialties > Pediatrics: General Medicine > Endocrinology

Hypomagnesemia

Author: James E Springate, MD, Associate Professor of Pediatrics, State University of New York at Buffalo; Attending Physician, Department of Pediatrics, Division of Pediatric Nephrology, Women & Children's Hospital of Buffalo
Coauthor(s): Gunjeet K Kala, MD, Clinical Instructor, Division of Pediatric Nephrology, University of Buffalo State University of New York School of Medicine and Biomedical Sciences, Women and Children's Hospital of Buffalo
Contributor Information and Disclosures

Updated: Sep 18, 2009

Introduction

Background

Magnesium (Mg) is the second-most abundant intracellular cation and, overall, the fourth-most abundant cation. Almost all enzymatic processes using phosphorus as an energy source require magnesium for activation. Magnesium is involved in nearly every aspect of biochemical metabolism (eg, DNA and protein synthesis, glycolysis, oxidative phosphorylation). Almost all enzymes involved in phosphorus reactions (eg, adenosine triphosphatase [ATPase]) require magnesium for activation. Magnesium serves as a molecular stabilizer of RNA, DNA, and ribosomes. Because magnesium is bound to ATP inside the cell, shifts in intracellular magnesium concentration may help regulate cellular bioenergetics such as mitochondrial respiration.

Extracellularly, magnesium ions block neurosynaptic transmission by interfering with the release of acetylcholine. Magnesium ions also may interfere with the release of catecholamines from the adrenal medulla. Magnesium has been proposed as an endogenous endocrine modulator of the catecholamine component of the physiologic stress response.

The total body content of magnesium in adults is about 2,000 mEq or 24 g. No data are available for children. Approximately 60% of total body magnesium is located in bone and the remainder is in the soft tissues. This soft tissue intracellular compartment comprises about 38% of total body magnesium; relatively higher concentrations are found in skeletal muscle and liver. Because less than 2% is present in the extracellular fluid (ECF) compartment, serum levels do not necessarily reflect the status of total body stores.

Serum concentration typically ranges from 1.8-2.5 mEq/L. Approximately a third of this is protein-bound. Analogous to plasma calcium, the free (ie, unbound) fraction of magnesium is the active component. No accurate method exists to assess ionized serum magnesium.

Magnesium is primarily absorbed in the small intestine at a rate ranging from 34 -3% of dietary intake. Absorption occurs primarily in the jejunum and ileum via ionic diffusion (passive) and at low concentrations through active transport processes. The sigmoid colon also has some capacity for magnesium absorption. A minimal daily intake of 0.3 mEq/kg of body weight has been suggested to prevent deficiency. Infants and children tend to have higher daily requirements.

The kidney is an important regulator of magnesium homeostasis. Magnesium elimination is predominantly renal; in adults, approximately 2.5 g of magnesium is filtered daily, 96% of which is reclaimed along the nephron. The threshold for urinary excretion is near the normal serum concentration. Thus, when serum levels rise above 2.5 mEq/L, magnesium excretion dramatically increases. Conversely, the kidney retains a strong capacity to reabsorb magnesium when serum levels fall. The main site for reabsorption is the thick ascending loop of Henle (70% of filtered load). Movement of magnesium in this nephron segment is passive and affected by both the lumen-positive transepithelial voltage as well as the highly negatively charged tight junction protein claudin-16, formerly known as paracellin-1. Active reabsorption of magnesium occurs in the distal convoluted tubule (5-10% of filtered load).

(A) Magnesium reabsorption in the thick ascending...

(A) Magnesium reabsorption in the thick ascending limb of the loop of Henle. The driving force for the reabsorption against a concentration gradient is a lumen-positive voltage gradient generated by the reabsorption of NaCl. FHHNC = Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. ADH = autosomal dominant hypocalcemia. FHH/NSHPT = Familial hypomagnesemia/neonatal severe hyperparathyroidism. (B) Magnesium reabsorption in the distal convoluted tubule. Active transcellular transport is mediated by an apical entry through a magnesium channel and a basolateral exit, presumably via a Na+/Mg2+ exchange mechanism. HSH = Hypomagnesemia with secondary hypocalcemia. GS = Gitelman syndrome. IDH = Isolated dominant hypomagnesemia. Source: Konrad M, Schlingmann KP, Gudermann T: Insights into the molecular nature of magnesium homeostasis. Am J Physiol Renal Physiol 2004; 286: F599-F605.

(A) Magnesium reabsorption in the thick ascending...

(A) Magnesium reabsorption in the thick ascending limb of the loop of Henle. The driving force for the reabsorption against a concentration gradient is a lumen-positive voltage gradient generated by the reabsorption of NaCl. FHHNC = Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. ADH = autosomal dominant hypocalcemia. FHH/NSHPT = Familial hypomagnesemia/neonatal severe hyperparathyroidism. (B) Magnesium reabsorption in the distal convoluted tubule. Active transcellular transport is mediated by an apical entry through a magnesium channel and a basolateral exit, presumably via a Na+/Mg2+ exchange mechanism. HSH = Hypomagnesemia with secondary hypocalcemia. GS = Gitelman syndrome. IDH = Isolated dominant hypomagnesemia. Source: Konrad M, Schlingmann KP, Gudermann T: Insights into the molecular nature of magnesium homeostasis. Am J Physiol Renal Physiol 2004; 286: F599-F605.


Pathophysiology

Hypomagnesemia is widespread among hospitalized patients and has been reported in as many as 60% of ICU patients.1 Prolonged administration of magnesium-free parenteral fluids may be a contributing factor. In general, the etiology of hypomagnesemia is usually a result of either renal or GI losses.

Renal causes are related to either primary tubular defects in reabsorption or disorders of tubular sodium reabsorption. These disorders include Gitelman syndrome and familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Effects of certain disease states or medications include diabetes, postobstructive diuresis, diuretic phase of acute tubular necrosis, loop or thiazide diuretics, cisplatin, aminoglycosides, pentamidine, foscarnet, tacrolimus, and cyclosporine A. The incidence of hypomagnesemia among people with alcohol dependence is approximately 25% and is mainly due to magnesium dieresis caused by alcohol. Severe hypomagnesemia may occur during the recovery phase of diabetic ketoacidosis. Patients with diabetes who have chronically poor glycemic control may have a total body magnesium deficit, possibly caused by ineffective insulin-mediated cellular uptake of magnesium as well as osmotic diuresis from glucosuria.2

GI causes are often related to prolonged nasogastric suction, infectious diarrhea, steatorrhea, inflammatory bowel disease, intestinal fistulas, malnutrition, primary infantile hypomagnesemia (autosomal recessive disease), and intestinal neoplasms.

Frequency

United States

Although the incidence of hypomagnesemia in the general population has been estimated at less than 2%, some studies have estimated that 75% of Americans do not meet the recommended dietary allowance of magnesium.3

Age

Although no comprehensive studies have addressed the actual incidence of hypomagnesemia stratified by age group, neonates may be more predisposed to develop hypomagnesemia. The mechanism for this is unknown, although several studies suggest that neonates have an increased requirement for intracellular magnesium in growing tissues.

Clinical

History

Magnesium deficiency and hypomagnesemia are often asymptomatic. Severe symptomatic hypomagnesemia may manifest clinically as tetany and generalized seizures. Early manifestations may include muscle cramps, nausea, vomiting, and lethargy.

At least 10 inherited disorders of magnesium handling cause hypomagnesemia.4 A careful family history is important, particularly when acquired causes of hypomagnesemia have been excluded.

Physical

At serum magnesium levels less than 1 mEq/L, patients have tremor, hyperactive deep-tendon reflexes, hyperreactivity to sensory stimuli, muscular fibrillations, positive Chvostek and Trousseau signs, and carpopedal spasms progressing to tetany. Mental status changes may become evident and may include irritability, disorientation, depression, and psychosis. Cardiac arrhythmias and reversible respiratory muscle failure can also occur in severe hypomagnesemia.

In a fashion analogous to hypermagnesemia, the rate of development of hypomagnesemia may be more important than the absolute value in terms of symptom development.

Causes

Major causes of magnesium deficiency include the following:

  • GI disorders
    • Long-term parenteral fluid therapy without supplementation
    • Prolonged nasogastric suction/vomiting
    • Diarrhea
    • Malabsorption syndromes
    • Extensive bowel resection
    • Intestinal or biliary fistulas
    • Acute pancreatitis
  • Renal disorders
    • Osmotic diuresis (eg, diabetes mellitus)
    • Hypercalcemia
    • Medications (eg, diuretics, aminoglycosides, calcineurin inhibitors)
    • Alcohol
    • Postobstructive diuresis
    • Diuretic phase of acute tubular necrosis
    • Inherited tubular diseases (eg, Gitelman syndrome, familial hypomagnesemia with hypercalciuria/nephrocalcinosis)

More on Hypomagnesemia

Overview: Hypomagnesemia
Differential Diagnoses & Workup: Hypomagnesemia
Treatment & Medication: Hypomagnesemia
Follow-up: Hypomagnesemia
Multimedia: Hypomagnesemia
References
Further Reading

References

  1. Tong GM, Rude RK. Magnesium deficiency in critical illness. J Intensive Care Med. Jan-Feb 2005;20(1):3-17. [Medline].

  2. Curiel-Garcia JA, Rodriguez-Moran M, Guerrero-Romero F. Hypomagnesemia and mortality in patients with type 2 diabetes. Magnes Res. Sep 2008;21(3):163-6. [Medline].

  3. Guerrera MP, Volpe SL, Mao JJ. Therapeutic uses of magnesium. Am Fam Physician. Jul 15 2009;80(2):157-62. [Medline].

  4. Naderi AS, Reilly RF Jr. Hereditary etiologies of hypomagnesemia. Nat Clin Pract Nephrol. Feb 2008;4(2):80-9. [Medline].

  5. Agus ZS. Hypomagnesemia. J Am Soc Nephrol. Jul 1999;10(7):1616-22. [Medline].

  6. Konrad M. Disorders of magnesium metabolism. In: Geary D, Shaefer F. Comprehensive Pediatric Nephrology. Philadelphia PA: Mosby Elsevier; 2008:461-475.

  7. Martin KJ, Gonzalez EA, Slatopolsky E. Clinical Consequences and Management of Hypomagnesemia. J Am Soc Nephrol. Jan 30 2008;[Medline][Full Text].

  8. [Best Evidence] Mouw DR, Latessa RA, Hickner J. Clinical inquiries. What are the causes of hypomagnesemia?. J Fam Pract. Feb 2005;54(2):174-6. [Medline][Full Text].

  9. Rodriguez-Hernandez H, Gonzalez JL, Rodriguez-Moran M, Guerrero-Romero F. Hypomagnesemia, insulin resistance, and non-alcoholic steatohepatitis in obese subjects. Arch Med Res. Jul-Aug 2005;36(4):362-6. [Medline].

  10. Topf JM, Murray PT. Hypomagnesemia and hypermagnesemia. Rev Endocr Metab Disord. May 2003;4(2):195-206. [Medline].

Keywords

hypomagnesemia, magnesium, Mg, infectious diarrhea, steatorrhea, inflammatory bowel disease, GI neoplasms, diabetic ketoacidosis, irritability, disorientation, depression, psychosis, treatment, diagnosis, low magnesium levels, treatment, diagnosis

Contributor Information and Disclosures

Author

James E Springate, MD, Associate Professor of Pediatrics, State University of New York at Buffalo; Attending Physician, Department of Pediatrics, Division of Pediatric Nephrology, Women & Children's Hospital of Buffalo
James E Springate, MD is a member of the following medical societies: American Academy of Pediatrics, American Physiological Society, American Society of Pediatric Nephrology, International Pediatric Transplant Association, and Society for Pediatric Research
Disclosure: Nothing to disclose.

Coauthor(s)

Gunjeet K Kala, MD, Clinical Instructor, Division of Pediatric Nephrology, University of Buffalo State University of New York School of Medicine and Biomedical Sciences, Women and Children's Hospital of Buffalo
Gunjeet K Kala, MD is a member of the following medical societies: American Academy of Pediatrics, American Society of Pediatric Nephrology, and American Society of Pediatric Nephrology
Disclosure: Nothing to disclose.

Medical Editor

Karl S Roth, MD, Professor and Chair, Department of Pediatrics, Creighton University School of Medicine
Karl S Roth, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American College of Nutrition, American Pediatric Society, American Society for Clinical Nutrition, American Society of Nephrology, Association of American Medical Colleges, Medical Society of Virginia, New York Academy of Sciences, Sigma Xi, Society for Pediatric Research, and Southern Society for Pediatric Research
Disclosure: MDS Pharma Salary Employment

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

George P Chrousos, MD, FAAP, MACP, MACE, FRCP(London), Professor and Chair, First Department of Pediatrics, Athens University Medical School, Aghia Sophia Children's Hospital, Greece
George P Chrousos, MD, FAAP, MACP, MACE, FRCP(London) is a member of the following medical societies: American Academy of Pediatrics, American College of Endocrinology, American College of Physicians, American Pediatric Society, American Society for Clinical Investigation, Association of American Physicians, Endocrine Society, Lawson-Wilkins Pediatric Endocrine Society, and Society for Pediatric Research
Disclosure: Nothing to disclose.

CME Editor

David Pallares, MD, Clinical Assistant Professor, Department of Pediatrics, Division of Allergy and Immunology, University of Louisville
David Pallares, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology
Disclosure: Nothing to disclose.

Chief Editor

Stephen Kemp, MD, PhD, Professor, Department of Pediatrics, Section of Pediatric Endocrinology, University of Arkansas and Arkansas Children's Hospital
Stephen Kemp, MD, PhD is a member of the following medical societies: American Academy of Pediatrics, American Association of Clinical Endocrinologists, American Pediatric Society, Endocrine Society, Phi Beta Kappa, Southern Medical Association, and Southern Society for Pediatric Research
Disclosure: Genentech, Inc. Honoraria Speaking and teaching; Pfizer, Inc. Honoraria Consulting

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.